Resources
Gastrointestinal and metabolic disorders are highly prevalent and result in reduced quality of life for many patients. Treatments are aimed at reducing symptoms and preventing complications and progression. More research is needed to better understand natural history and progression, treatment effectiveness, and outcomes. Register here Linked real-world data (RWD) and machine learning (ML) applications provide[…]
July 19, 2022 11:00 AM EDT Register>> Real-world data (RWD) can provide valuable insights into treatment effectiveness and be used to generate evidence for decision making. Understanding which data, when and how to use it, and special considerations when leveraging for regulatory and other stakeholders are all critical to success for RWD comparative effectiveness research[…]
Tue. June 28, 2022 11:00AM – 12:00PM Register >> Identifying patients in real-world data contexts can be difficult, especially when clinical coding is imprecise or unavailable. This webinar will dive into how artificial intelligence tools and real-world data can provide powerful solutions to these challenges. We will discuss how to approach: Conditions with new, underutilized[…]
THU, JUN 9, 2022 11:00 AM – 12:00 PM EDT Register >> Assessing clinical and functional status in Multiple Sclerosis (MS) using the Expanded Disability Status Scale (EDSS) is critical to inform treatment decisions and monitoring the progression of illness. Yet, EDSS scores are documented infrequently and inconsistently due to the time required to complete[…]
Thu, May 26, 2022 11:00 AM – 12:00 PM EDT Register>> As the call for more diversity in clinical research grows, new approaches are needed to ensure patients of different genders, ethnicities, income brackets, and other under-represented populations are included in the evaluation of treatment access, effectiveness, and safety. Real-world data (RWD) can help with[…]
